Production of n.c.a. Lutetium-177 / EndolucinBeta® for Targeted Radionuclide Therapy

EndolucinBeta® is a radiopharmaceutical precursor and it is indicated for the radiolabeling of disease-specific carrier molecules in nuclear medicine.